Valsartan for Suppression of Plaque Volume and Restenosis After Drug-Eluting Stent

NCT00589732 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

220

Enrollment

OTHER

Sponsor class

Conditions

Coronary Artery Disease

Interventions

DRUG: Valsartan

Sponsor

Seung-Jung Park

Collaborators

[object Object]